Skip to main content
SpringerLink
Log in

De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kreipe H, Hussein K, Göhring G, Schlegelberger B (2011) Progression of myeloproliferative neoplasms to myelofibrosis and acute leukaemia. J Hematopathol 4:61–68

    Article  Google Scholar 

  2. Swerdlow SH, Campo E, Harris NL, Jaffe SS, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon

    Google Scholar 

  3. Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D, Weinzierl E, Hatem J, Jaso J, Kanagal-Shamanna R, Stingo FC, Patel KP, Mehrotra M, Bueso-Ramos C, Young KH, Dinardo CD, Verstovsek S, Tiu RV, Bagg A, Hsi ED, Arber DA, Foucar K, Luthra R, Orazi A (2014) Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood 123:2645–2651. doi:10.1182/blood-2014-02-553800

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, Bottomly D, Wilmot B, McWeeney SK, Tognon CE, Pond JB, Collins RH, Goueli B, Oh ST, Deininger MW, Chang BH, Loriaux MM, Druker BJ, Tyner JW (2013) Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 368:1781–1790. doi:10.1056/NEJMoa1214514

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, Ketterling RP, Maxson JE, Tyner JW, Tefferi A (2013) CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 27:1870–1873. doi:10.1038/leu.2013.122

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Hasemeier B, Geffers R, Bartels S, Schlegelberger B, Kreipe H, Lehmann U (2013) Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technology. Haematologica 98:e115–e116. doi:10.3324/haematol.2013.091652

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Lehmann U, Bartels S, Hasemeier B, Geffers R, Schlue J, Büsche G, Hussein K, Kreipe H (2013) SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis. Blood 121:4011–4012. doi:10.1182/blood-2012-11-467662

    Article  CAS  PubMed  Google Scholar 

  8. Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda RC (2014) Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 123:2220–2228. doi:10.1182/blood-2013-11-537167.

    Article  CAS  PubMed  Google Scholar 

  9. Piazza R, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A, Antolini L, Mologni L, Donadoni C, Papaemmanuil E, Schnittger S, Kim DW, Boultwood J, Rossi F, Gaipa G, De Martini GP, di Celle PF, Jang HG, Fantin V, Bignell GR, Magistroni V, Haferlach T, Pogliani EM, Campbell PJ, Chase AJ, Tapper WJ, Cross NC, Gambacorti-Passerini C (2013) Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet 45:18–24. doi:10.1038/ng.2495

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Lasho TL, Mims A, Elliott MA, Finke C, Pardanani A, Tefferi A (2014) Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib. Leukemia 28:1363–1365. doi:10.1038/leu.2014.39

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by a grant of the Deutsche Krebshilfe to HK and GB (Grant Number 1097154, TP A,D)

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Institute of Pathology, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Germany

    S. Bartels, U. Lehmann, G. Büsche, J. Schlue, K. Hussein & H. Kreipe

  2. Onkologische Schwerpunktpraxis Heidelberg, Heidelberg, Germany

    D. Debatin & A. Karcher

  3. Institute of Pathology, University of Heidelberg, Heidelberg, Germany

    M. Andrulis & P. Schirmacher

Authors
  1. S. Bartels
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Büsche
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Schlue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Hussein
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Debatin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Karcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Andrulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Schirmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H. Kreipe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Kreipe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bartels, S., Lehmann, U., Büsche, G. et al. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML. Ann Hematol 94, 1255–1256 (2015). https://doi.org/10.1007/s00277-015-2366-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2366-3

Keywords

Search

Navigation